Meanwhile, the TIM3 expression on CD4+ T cells and CD8+ T cells was down‐regulated by the blockade of TIM3, especially in tumor and LN (Fig. 6D,F), as the ratio of TIM3+ cells in CD4+ or CD8+ T cells was found to be decreased. Here, HAVCR2 is linked to neoplasm.